These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 27388807)
41. Trends in colorectal cancer screening over time for persons with and without chronic disability. Iezzoni LI; Kurtz SG; Rao SR Disabil Health J; 2016 Jul; 9(3):498-509. PubMed ID: 27130194 [TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test. Lejeune C; Dancourt V; Arveux P; Bonithon-Kopp C; Faivre J Int J Technol Assess Health Care; 2010 Jan; 26(1):40-7. PubMed ID: 20059779 [TBL] [Abstract][Full Text] [Related]
43. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy. Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404 [TBL] [Abstract][Full Text] [Related]
45. Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening. Berchi C; Guittet L; Bouvier V; Launoy G Int J Technol Assess Health Care; 2010 Jan; 26(1):48-53. PubMed ID: 20059780 [TBL] [Abstract][Full Text] [Related]
46. Early detection of colorectal cancer with faecal occult blood test screening. Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855 [TBL] [Abstract][Full Text] [Related]
47. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing. Wong CK; Lam CL; Wan YF; Fong DY BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036 [TBL] [Abstract][Full Text] [Related]
48. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing. Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350 [TBL] [Abstract][Full Text] [Related]
49. Using specialist screening practitioners (SSPs) to increase uptake of bowel scope (flexible sigmoidoscopy) screening: results of a feasibility single-stage phase II randomised trial. McGregor LM; Skrobanski H; Ritchie M; Berkman L; Miller H; Freeman M; Patel N; Morris S; Rees C; von Wagner C BMJ Open; 2019 Feb; 9(2):e023801. PubMed ID: 30772850 [TBL] [Abstract][Full Text] [Related]
50. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea. Bae N; Park S; Lim S Eur J Oncol Nurs; 2014 Feb; 18(1):72-7. PubMed ID: 24183583 [TBL] [Abstract][Full Text] [Related]
51. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. Choi KS; Lee HY; Jun JK; Shin A; Park EC J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224 [TBL] [Abstract][Full Text] [Related]
52. Patient navigation for breast and colorectal cancer in 3 community hospital settings: an economic evaluation. Donaldson EA; Holtgrave DR; Duffin RA; Feltner F; Funderburk W; Freeman HP Cancer; 2012 Oct; 118(19):4851-9. PubMed ID: 22392629 [TBL] [Abstract][Full Text] [Related]
53. Components and effectiveness of patient navigation programmes to increase participation to breast, cervical and colorectal cancer screening: A systematic review. Mosquera I; Todd A; Balaj M; Zhang L; Benitez Majano S; Mensah K; Eikemo TA; Basu P; Carvalho AL Cancer Med; 2023 Jul; 12(13):14584-14611. PubMed ID: 37245225 [TBL] [Abstract][Full Text] [Related]
54. Clinical case management and navigation for colonoscopy screening in an academic medical center. Cavanagh MF; Lane DS; Messina CR; Anderson JC Cancer; 2013 Aug; 119 Suppl 15():2894-904. PubMed ID: 23868484 [TBL] [Abstract][Full Text] [Related]
55. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province. Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773 [TBL] [Abstract][Full Text] [Related]
56. An economic evaluation of colorectal cancer screening in primary care practice. Meenan RT; Anderson ML; Chubak J; Vernon SW; Fuller S; Wang CY; Green BB Am J Prev Med; 2015 Jun; 48(6):714-21. PubMed ID: 25998922 [TBL] [Abstract][Full Text] [Related]
57. What Is Organized Screening and What Is Its Value? Dominitz JA; Levin TR Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):393-411. PubMed ID: 32439078 [TBL] [Abstract][Full Text] [Related]
58. Comparative Effectiveness of Multifaceted Outreach to Initiate Colorectal Cancer Screening in Community Health Centers: A Randomized Controlled Trial. Goldman SN; Liss DT; Brown T; Lee JY; Buchanan DR; Balsley K; Cesan A; Weil J; Garrity BH; Baker DW J Gen Intern Med; 2015 Aug; 30(8):1178-84. PubMed ID: 25814264 [TBL] [Abstract][Full Text] [Related]
59. The effectiveness of the FLU-FOBT program in primary care a randomized trial. Potter MB; Walsh JM; Yu TM; Gildengorin G; Green LW; McPhee SJ Am J Prev Med; 2011 Jul; 41(1):9-16. PubMed ID: 21665058 [TBL] [Abstract][Full Text] [Related]
60. Patient Navigation in a Colorectal Cancer Screening Program. Escoffery C; Fernandez ME; Vernon SW; Liang S; Maxwell AE; Allen JD; Dwyer A; Hannon PA; Kohn M; DeGroff A J Public Health Manag Pract; 2015; 21(5):433-40. PubMed ID: 25140407 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]